Lawrence P. Wennogle, Vice President, Drug Discovery at Intra-Cellular Therapies, Inc. (ITCI), sold 4,745 shares at $15.00 ($71K) on 2014-10-08, disclosed to the SEC on 2014-10-10.
Scheduled sale ($71k) by Vice President, Drug Discovery under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ITCI | SELL | 2014-10-15 | $54K | — | Filing → |
| ITCI | SELL | 2014-10-07 | $247K | — | Filing → |
| ITCI | SELL | 2014-09-17 | $75K | — | Filing → |